期刊文献+

左旋精氨酸对高原肺水肿患者血清一氧化氮合酶活性的影响 被引量:2

Effect of L-arginine on the activity of nitric oxide synthetase in patients with high altitude pulmonary edema
原文传递
导出
摘要 目的 探讨左旋精氨酸 (L- Arg)对高原肺水肿 (HAPE)治疗前后一氧化氮合酶 (NOS)的影响。 方法 在海拔 370 0 m采用静脉滴注 L- Arg治疗 HAPE患者 8例 ,并与吸入低浓度一氧化氮 (NO)混合气治疗的 8例 HAPE患者作对照 ,分别检测血中 NO及 NOS含量。 结果 吸入 NO组和 L- Arg组治愈后较治疗前 NO、NOS均增高显著 (P<0 .0 5或 P<0 .0 1) ;吸入 NO组较 L- Arg组治疗后 NO及 NOS均无统计学差异 (P>0 .0 5 )。 结论 吸入 NO和静滴 L- Arg均可提高 HAPE患者 NOS活性 ,但 L- Arg更经济简便 ,易于推广应用。 Objective To explore the effect of L-arginine(L-Arg) on plasma level of nitric oxide synthetase (NOS) in patients with high altitude pulmonary edema (HAPE). Methods In the clinic at 3 700 m altitude, 8 cases of HAPE were treated with L-Arg (20 g) intravenous instillation on the basis of routine treatment (L-Arg group), and other 8 cases of HAPE were treated with low concentration (0.001%) NO gas mixture inhalation (NO group) in addition to routine treatment. Their plasma levels of NO and NOS were examined before treatment and after recovery. Results As compared with those before treatment the plasma NO and NOS levels in patients after recovery were significantly increased both in Arg group and NO group (P<0.05, P<0.01). The differences between plasma NO and NOS levels of Arg group and NO group patients were non-significant before treatment and after recovery. Conclusion Both NO inhalation and L-Arg instillation can improve the plasma level of NOS in HAPE patients, and L-Arg instillation is more economical and easy to operate.
出处 《中华航空航天医学杂志》 CSCD 2002年第1期51-53,共3页 Chinese Journal of Aerospace Medicine
关键词 高海拔 肺水肿 左旋精氨酸 一氧化氮 一氧化氮合酶 Altitude Pulmonary edema L-Arginine Nitric oxide Nitric-oxide synthetase
  • 相关文献

参考文献9

  • 1Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 1991,83(6):2038-2047.
  • 2Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet,1991,338(8776):1173-1174.
  • 3高原病命名与临床分型意见[J].高原医学杂志,1995,5(3):1-2. 被引量:35
  • 4崔建华,张西洲,何富文,周新梅,哈振德,王正理.不同海拔高度居住高原不同时间健康青年血浆内皮素和一氧化氮的测定[J].西藏医药,1999,20(4):1-2. 被引量:16
  • 5Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. New Engl J Med,1995,333(4):214-221.
  • 6Kouyoumdjian C, Adnot S, Levame M, et al. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest,1994,94(2):578-584.
  • 7Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest, 1989,83(5):1774-1777.
  • 8Eddahibi S, Adnot S, Carville C, et al. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol,1992,263(2 Pt 1):L194-200.
  • 9Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation, 1993,88(6):2884-2887.

共引文献49

同被引文献15

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部